Expression of Cyclooxygenase-2 (COX-2) in Colorectal Adenocarcinoma: an Immunohistochemical and Histopathological Study |
Mahmoud, Abla Sayed
(Department of Oral Maxillofacial Sciences, Alfarabi College of Dentistry)
Umair, Ayesha (Department of Oral Maxillofacial Sciences, Alfarabi College of Nursing and Dentistry) Azzeghaiby, Saleh Nasser (Department of Oral Maxillofacial Sciences, Alfarabi College of Nursing and Dentistry) Alqahtani, Fahad Hussain (Department of Oral Maxillofacial Sciences, Alfarabi College of Nursing and Dentistry) Hanouneh, Salah (Department of Oral Maxillofacial Sciences, Alfarabi College of Nursing and Dentistry) Tarakji, Bassel (Department of Oral Maxillofacial Sciences, Alfarabi College of Nursing and Dentistry) |
1 | Al-Maghrabi J, Buhmeida A, Emam E, et al (2012). Cyclooxygenase-2 expression as a predictor of outcome in colorectal carcinoma. World J Gastroenterol, 18, 1793-9. DOI |
2 | Bottone FG, Martinez, JM, Alston-Mills B, Eling TE (2004). Gene modulation by Cox-1 and Cox-2 specific inhibitors in human colorectal carcinoma cancer cells. Carcinogenesis, 25, 349-57. |
3 | Christudoss P, Selvakumar R, Pulimood AB, et al (2013). Protective role of aspirin, vitamin C, and zinc and their effects on zinc status in the DMH-induced colon carcinoma model. Asian Pac J Cancer Prev, 8, 4627-34. 과학기술학회마을 DOI |
4 | Dempke W, Rie C, Grothey A (2001). Cyclooxygenase-2: A novel target for cancer chemotherapy. J Cancer Res Clin Oncol, 127, 411-7. DOI ScienceOn |
5 | Elzagheid A, Emaetig F, Alkikhia L, et al (2013). High cyclooxygenase-2 expression is associated with advanced stages in colorectal cancer. Anticancer Res, 33, 3137-43. |
6 | Fatemi SR, Malek FN, Shivarani S, et al (2010). Prevalence of colorectal cancer in relatives of Iranian patients diagnosed with colorectal cancer. Asian Pac J Cancer Prev, 1, 91-3. |
7 | Harris RE (2007): Cyclooxygenase-2 (COX-2) and the inflammogenesis of cancer. Subcell Biochem, 42, 93-126. DOI |
8 | Jemal A, Bray F, Center MM, et al (2011). Global cancer statistics. CA Cancer J Clin, 61, 69-90. DOI |
9 | Kim JY, Lim SJ, Park K (2004). Cyclooxygenase-2 and c-erbB-2 expression in colorectal carcinoma assessed using tissue microarrays. Appl Immunohistochem Mol Morphol, 1, 67-70. |
10 | Karahan N, Guney M, Baspinar S, et al (2007). Expression of gelatinase (MMP-2 and MMP-9) and cyclooxygenase-2 (COX-2) in endometrial carcinoma. Eur J Gynaeol Oncol, 28, 184-8. |
11 | Kawamori T, Uchiya N, Sugimura (2003). Enhancement of colon carcinogenesis by prostaglandin E2 administration. Carcinogenesis, 24, 985-90. DOI |
12 | Sameer AS, Shah ZA, Syeed N, et al (2010). NAD(P) H:quinoneoxidoreductase 1 (NQO1) Pro187Ser polymorphism and colorectal cancer predisposition in the ethnic Kashmiri population. Asian Pac J Cancer Prev, 11, 209-13. |
13 | Sonoshita M, Takaku K, Oshima M (2002). Cyclooxygenase-2 expression in fibroblasts and endothelial cells of intestinal polyps. Cancer Res, 62, 6846-9. |
14 | Soumaoro LT, Uetake H, Higuchi T (2004).Cyclooxygenase-2 expression, Asignificant prognostic indicator for patients with colorectal cancer. Clin Cancer Res, 10, 8465-71. DOI ScienceOn |
15 | Smyrk TC (2002). Colorectal cancer pathology. In Gastrointestinal oncology principles and practice. Lippincott Williams and Wilkins, Philadelphia, 717-30. |
16 | Tsujii M, Kawano S, Tsuji S, et al (1998). Cyclooxygenase regulates angiogenesis induced by colon cancer cells. Cell, 93, 705-16. DOI ScienceOn |
17 | Tomozawa S, Tsuno NH, Sunami E (2000). Cyclooxygenase -2 overexpression correlates with tumour recurrence, especially haematogenous metastasis of colorectal cancer. Br J Cancer, 83, 324-8. DOI ScienceOn |
18 | Tuynman JB, Buskens, Kemper K(2005). Neo-adjuvant selective cox-2 inhibition down-regulates important oncogenic pathway with esophageal adenocarcinoma. Ann Sur, 242, 840-9. DOI |
19 | Wu AW, Gu J, Ji JF, Li ZF, Xu GW (2003). Role of COX-2 in carcinogenesis of colorectal cancer and its relationship with tumor biological characteristics and patients' prognosis. World J Gastroenterol, 9, 1990-4. |
20 | Xu YS, Zhao B, Long CY, et al (2014).Cyclooxygenase-2 promoter 765C increase of digestive tract cancer risk in the Chinese population: a meta-analysis. Asian Pac J Cancer Prev, 11, 4563-6. 과학기술학회마을 DOI |
21 | Shalaby MA, Nounou HA, Ms A, et al (2014). Associations between single nucleotide polymorphisms of COX-2 and MMP-2 genes and colorectal cancer susceptibility in the Saudi population. Asian Pac J Cancer Prev, 12, 4989-94 과학기술학회마을 DOI ScienceOn |
22 | Zhou LH, Hu Q, Sui H, et al (2012). Tanshinone II--a inhibits angiogenesis through down regulation of COX-2 in human colorectal cancer. Asian Pac J Cancer Prev, 13, 4453-8. 과학기술학회마을 DOI ScienceOn |
23 | Zhang H, Sun XF (2002). Overexpression of cyclooxygenase-2 correlates with advanced stages of colorectal cancer. Am J Gastroenterol, 97, 1037-41. DOI ScienceOn |
24 | Fux R, Schwab M, Thon KP, Gleiter CH, Fritz P (2005). Cyclooxygenase-2 expression in human colorectal cancer is unrelated to overall patient survival. Clin Cancer Res, 11, 4754-60. DOI ScienceOn |